providing funding and strategic support to innovative companies. 
 
   Helsinn Group plays an active and central role in promoting social 
transformation in favor of people and the environment. Corporate social 
responsibility is at the heart of everything we do which is reinforced 
in the company's strategic plan by a commitment to sustainable growth. 
 
   To learn more about Helsinn Group please visit 
https://www.globenewswire.com/Tracker?data=9S4rAewVzF_GVUwS9HVtM3Jhz3cr18VxAlpwsJQXeWk1Bh-xV_exihiZoAuf-V_E4gh_NnVt4xkrosABAVWItRuP6XLDpLnm5QtiJfws5ivxCQ84u4VVUxRV7f_9cfTfDPxQYYtNHQ5Tt1UOMTXeFGNTGJroR3zLMCaalDKWd4K6fOjq5hZYnAXAaEtZLATb1tGanE9tbKIqEEWwW9YFfJLUCLescS431keaji0pdMY= 
www.helsinn.com 
 
   About Kyowa Kirin 
 
   Kyowa Kirin commits to innovative drug discovery driven by 
state-of-the-art technologies. The company focuses on creating new 
values in the four therapeutic areas: nephrology, oncology, 
immunology/allergy and neurology. Under the Kyowa Kirin brand, the 
employees from 40 group companies across North America, EMEA, and 
Asia/Oceania unite to champion the interests of patients and their 
caregivers in discovering solutions wherever there are unmet medical 
needs. You can learn more about the business of Kyowa Kirin at: 
https://www.globenewswire.com/Tracker?data=CH90n_MgisFDtbRNXijHzn0RS88MyEjWe5LjGk9rn6JlMA39ExBlaq1yz2NyGZUgkvoLBZOjQuz7MIt8dILij7K3tikUhDObyvg9BNAX9U4= 
https://www.kyowakirin.com 
 
   For more information: 
 
   Helsinn Group Media Contact: 
 
   Paola Bonvicini 
 
   Group Head of Communication 
 
   Lugano, Switzerland 
 
   Tel: +41 (0) 91 985 21 21 
 
   Email: Info-hhc@helsinn.com 
https://www.globenewswire.com/Tracker?data=hEfB6fiTdrHfeL5Jm_cF013gdtsKivCpO0ifXhA6_v6kCrgYEPYsDy4zMnwR6OCbG5gz18H0kBOmQAzWjY_K61gmgq0wVNiGgW6mI_x3KHY= 
 
 
   For more information, please visit www.helsinn.com and follow us on 
Twitter 
https://www.globenewswire.com/Tracker?data=zgyu1eS7wXtBt65JYDFeij6zkSdB9FUgwqVOtZ7MxuhGlSci9j_sMkAVUxcU1BwFic7R6B4FmC5qrfFljCoCjA== 
, LinkedIn 
https://www.globenewswire.com/Tracker?data=Jqhrb9oFnZ0HS0hh-FLEtbHE9LSXfYWUpuWYz_G3pBLYX_ZdN2XfjpXIb0qIkJZKJzS1ARO2i3sWGCJk1gI3wx_-dKIvtzxaQ0NyzsrbCF4= 
and Vimeo 
https://www.globenewswire.com/Tracker?data=YctLQiZ-IwX2Q96te5z3RAhm2OIysbhhMwRqTllDKEchXhNYSU0HYvTuamYPjjVNas95RGb2LH78ZhmWXUrvnQ== 
 
 
   Kyowa Kirin Asia Pacific Media Contact: 
 
   Jasminder Kaur 
 
   Corporate Communications, APAC 
 
   Singapore 
 
   Tel: +65 8725 2790 
 
   Email: 
https://www.globenewswire.com/Tracker?data=7dvQ4G2zYC6qyS3cyTcUssoAJDaGdB2TORZ5f9-8PCyDePGfmbk70MdwdiT8ZP_VK7JypWdotaeFxQiAja0PvDZitaKH0l-pJWUwJ8ClmlckH0UG3OGfoP13Hzc2P7YzwOw2uCpOG4XzoPoZLSgeRw== 
jasminder.kaur.5r@1kyowakirin.com 
 
   For more information, please visit www.kyowakirin.com and follow us on 
https://www.globenewswire.com/Tracker?data=Jqhrb9oFnZ0HS0hh-FLEtfP0KjuGo0f-HqgRZHuMxDm_sFqQ-X4ZFM1Zgwbl-YH59tfGz2-rIj23Fc5QUdugxFl9XdWcPdrQT3dytblsB5lEF-ZNcWC5_x8T9KUVe5DI 
LinkedIn 
 
   HELS--0007 
 
   (1) Journal of Dermatology; 2014; 41: 43--49; doi: 
10.1111/1346-8138.12346; 
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.12346 
 
   (2) International Journal of Stroke; 2016; 0(0): 1--2; doi: 
10.1177/1747493016633302 
 
   (3) Australasian Journal of Dermatology; 2006; 47: 248--252; doi: 
10.1111/j.1440-0960.2006.00290.x

(END) Dow Jones Newswires

December 01, 2020 02:30 ET (07:30 GMT)